The histone acetyltransferase hMOF suppresses hepatocellular carcinoma growth

Jin Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ze‐Ya Pan(Second Military Medical University), Yun Yang(Tongji University), Weiping Zhou(Shenyang Medical College), Gang Huang(Shanghai Jiao Tong University), Yuan Yang(Central South University), Hào Pān(Shanghai Municipal Center For Disease Control Prevention), Hui Liu(Second Military Medical University)
Biochemical and Biophysical Research Communications
August 30, 2014
10.1016/j.bbrc.2014.08.122
Cited by 40

Related Papers

Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT
|Journal of Hepatology|2014|335
microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity
|British Journal of Cancer|2010|252
LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients
|Journal of Experimental & Clinical Cancer Research|2018|231
Antiviral Therapy Improves Postoperative Survival in Patients With Hepatocellular Carcinoma
|Annals of Surgery|2014|229
A Prospective, Randomized, Controlled Trial of Preoperative Transarterial Chemoembolization for Resectable Large Hepatocellular Carcinoma
|Annals of Surgery|2009|227